Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment

ABSTRACT:

SUBMITTER: Ylisaukko-oja T 

PROVIDER: S-EPMC11225725 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature